An intravenous loading dose of azathioprine decreases the time to response in patients with Crohn's disease
- 1 December 1995
- journal article
- clinical trial
- Published by Elsevier in Gastroenterology
- Vol. 109 (6) , 1808-1817
- https://doi.org/10.1016/0016-5085(95)90747-5
Abstract
No abstract availableKeywords
This publication has 38 references indexed in Scilit:
- 6-mercaptopurine (6-MP) metabolite measurement in IBD patients' neutrophils correlates with drug efficacy:Gastroenterology, 1995
- Azathioprine pharmacokinetics following single dose IV, oral, delayed-release oral and rectal foam administration:Gastroenterology, 1995
- Low-dose 6-mercaptopurine in inflammatory bowel disease is associated with minimal hematologic toxicityDigestive Diseases and Sciences, 1994
- Efficacy of cyclosporine in treatment of fistula of crohn's diseaseDigestive Diseases and Sciences, 1994
- Genetic variation in response to 6-mercaptopurine for childhood acute lymphoblastic leukaemiaThe Lancet, 1990
- Azathioprine Metabolism: Pharmacokinetics of 6‐Mercaptopurine, 6‐Thiouric Acid and 6‐Thioguanine Nucleotides in Renal Transplant PatientsThe Journal of Clinical Pharmacology, 1990
- A Placebo-Controlled, Double-Blind, Randomized Trial of Cyclosporine Therapy in Active Chronic Crohn's DiseaseNew England Journal of Medicine, 1989
- Serum azathioprine and 6-mercaptopurine levels and immunosuppressive activity after azathioprine in uremic patientsInternational Journal of Immunopharmacology, 1986
- Favorable effect of 6-Mercaptopurine on fistulae of Crohn's diseaseDigestive Diseases and Sciences, 1985
- A controlled trial of azathioprine in Crohn's diseaseDigestive Diseases and Sciences, 1975